Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Eloxx Pharmaceuticals, Inc.
Report date December 19, 2017 · Filed December 22, 2017
Section 16 reporting ended · disclosed 2017-12-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2027-12-19 | Direct | 27,500 |
Reported balance
After 2017-12-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-12-19 · Grant · Acquired 27,500 · Balance 27,500 F1: Such options were granted to Mr. Rector under Sevion Therapeutics Inc.'s ("Sevion's") 2008 Incentive Compensation Plan for services performed during Sevion's fiscal year ended June 30, 2017 and the portion of Sevion's fiscal year ended June 30, 2018 leading up to the closing of Sevion's transaction with Eloxx Pharmaceuticals, Ltd. (the "Transaction"), which occurred on December 19, 2017. In connection with the closing of the Transaction, Sevion effected a 1-for-20 reverse stock split and changed its corporate name to "Eloxx Pharmaceuticals, Inc." Such options were granted on a post-split basis and are immediately exercisable at an exercise price of $6.00 per share, which is equal to the closing selling price of Sevion's common stock on December 19, 2017, as reflected on a post-split basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Such options were granted to Mr. Rector under Sevion Therapeutics Inc.'s ("Sevion's") 2008 Incentive Compensation Plan for services performed during Sevion's fiscal year ended June 30, 2017 and the portion of Sevion's fiscal year ended June 30, 2018 leading up to the closing of Sevion's transaction with Eloxx Pharmaceuticals, Ltd. (the "Transaction"), which occurred on December 19, 2017. In connection with the closing of the Transaction, Sevion effected a 1-for-20 reverse stock split and changed its corporate name to "Eloxx Pharmaceuticals, Inc." Such options were granted on a post-split basis and are immediately exercisable at an exercise price of $6.00 per share, which is equal to the closing selling price of Sevion's common stock on December 19, 2017, as reflected on a post-split basis.
POLARITYTE, INC.
Report date December 01, 2016 · Filed December 05, 2016
Section 16 reporting ended · disclosed 2016-12-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 40,000 |
Reported balance
After 2016-12-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-01 · Grant · Acquired 15,000 · Balance 40,000 F1: Represents a restricted stock award (the "Restricted Stock Award") pursuant to the Issuer's 2017 Equity Incentive Plan (the "Plan"), which Plan is subject to stockholder approval. F2: Represents (i) the Restricted Stock Award, (ii) a restricted stock award of 16,667 shares granted pursuant to the Issuer's 2014 Equity Incentive Plan and (iii) a restricted stock award of 8,333 shares granted pursuant to the Issuer's 2016 Equity Incentive Plan of which 50% vested on April 25, 2016 and 50% vested on December 1, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock award (the "Restricted Stock Award") pursuant to the Issuer's 2017 Equity Incentive Plan (the "Plan"), which Plan is subject to stockholder approval.
F2: Represents (i) the Restricted Stock Award, (ii) a restricted stock award of 16,667 shares granted pursuant to the Issuer's 2014 Equity Incentive Plan and (iii) a restricted stock award of 8,333 shares granted pursuant to the Issuer's 2016 Equity Incentive Plan of which 50% vested on April 25, 2016 and 50% vested on December 1, 2016.
U.S. GOLD CORP.
Report date October 30, 2020 · Filed November 04, 2020
Section 16 reporting ended · disclosed 2020-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,671 |
Reported balance
After 2020-10-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-10-30 · Grant · Acquired 18,502 · Balance 99,671 F1: Represents restricted shares of common stock awarded to the reporting person pursuant to the terms of that certain general release and severance agreement between the Reporting Person and the Issuer, dated September 17, 2020 and the U.S. Gold Corp. 2020 Stock Incentive Plan. Such shares vested immediately upon grant. F2: On March 19, 2020, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split on a post-split basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of common stock awarded to the reporting person pursuant to the terms of that certain general release and severance agreement between the Reporting Person and the Issuer, dated September 17, 2020 and the U.S. Gold Corp. 2020 Stock Incentive Plan. Such shares vested immediately upon grant.
F2: On March 19, 2020, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split on a post-split basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2020 Filed Nov 4, 2020 01:30 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantCommon Stock | 18,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-020429 · ownership.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,671 F1 · shares: Represents restricted shares of common stock awarded to the reporting person pursuant to the terms of that certain general release and severance agreement between the Reporting Person and the Issuer, dated September 17, 2020 and the U.S. Gold Corp. 2020 Stock Incentive Plan. Such shares vested immediately upon grant. F2 · balance_after: On March 19, 2020, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split on a post-split basis. Read SEC document |
| September 16, 2020 Filed Sep 19, 2020 00:35 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantStock Option (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $14.70 | Not disclosed |
DisclosureSEC source: 0001493152-20-018042 · ownership.xml · derivative · entry 2 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-12-22 F1 · kind: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 22, 2017 and provided for one-quarter vesting on December 22, 2017 and the remaining three-quarters to vest in equal yearly installments over a three-year period. Vesting was accelerated for 6,250 options that otherwise would not vest due to the reporting person's termination of employment with the Issuer prior to the vesting date. The post-termination exercise period was extended to December 22, 2022. F1 · price: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 22, 2017 and provided for one-quarter vesting on December 22, 2017 and the remaining three-quarters to vest in equal yearly installments over a three-year period. Vesting was accelerated for 6,250 options that otherwise would not vest due to the reporting person's termination of employment with the Issuer prior to the vesting date. The post-termination exercise period was extended to December 22, 2022. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 22, 2017 and provided for one-quarter vesting on December 22, 2017 and the remaining three-quarters to vest in equal yearly installments over a three-year period. Vesting was accelerated for 6,250 options that otherwise would not vest due to the reporting person's termination of employment with the Issuer prior to the vesting date. The post-termination exercise period was extended to December 22, 2022. Read SEC document |
| September 16, 2020 Filed Sep 19, 2020 00:35 UTC | U.S. GOLD CORP. USAU · Entity 6127 | Disposition to issuerStock Option (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $14.70 | Not disclosed |
DisclosureSEC source: 0001493152-20-018042 · ownership.xml · derivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2022-12-22 F2 · derivative.exercise_price: The securities and exercise prices shown have been adjusted from the time of grant to reflect the Issuer's 1-for-10 reverse stock split on March 17, 2020. F1 · kind: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 22, 2017 and provided for one-quarter vesting on December 22, 2017 and the remaining three-quarters to vest in equal yearly installments over a three-year period. Vesting was accelerated for 6,250 options that otherwise would not vest due to the reporting person's termination of employment with the Issuer prior to the vesting date. The post-termination exercise period was extended to December 22, 2022. F2 · shares: The securities and exercise prices shown have been adjusted from the time of grant to reflect the Issuer's 1-for-10 reverse stock split on March 17, 2020. F1 · price: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 22, 2017 and provided for one-quarter vesting on December 22, 2017 and the remaining three-quarters to vest in equal yearly installments over a three-year period. Vesting was accelerated for 6,250 options that otherwise would not vest due to the reporting person's termination of employment with the Issuer prior to the vesting date. The post-termination exercise period was extended to December 22, 2022. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 22, 2017 and provided for one-quarter vesting on December 22, 2017 and the remaining three-quarters to vest in equal yearly installments over a three-year period. Vesting was accelerated for 6,250 options that otherwise would not vest due to the reporting person's termination of employment with the Issuer prior to the vesting date. The post-termination exercise period was extended to December 22, 2022. F2 · derivative.underlying_shares: The securities and exercise prices shown have been adjusted from the time of grant to reflect the Issuer's 1-for-10 reverse stock split on March 17, 2020. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 20:43 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-000623 · ownership.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 811,692 F1 · shares: Represents restricted stock awarded to the reporting person on January 14, 2020 pursuant to the U.S. Gold Corp. 2020 Stock Incentive Plan (the "Plan"). Such shares vested immediately upon grant. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 19:33 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantCommon Shares | 183,692 | $0.98 | $179,999.79 |
DisclosureSEC source: 0001567619-19-008834 · doc1.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,692 F1 · date: To be issued after 4/30/2019. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:09 UTC | U.S. GOLD CORP. USAU · Entity 6127 | PurchaseCommon Shares | 8,700 | $0.83 | $7,247.97 |
DisclosureSEC source: 0001567619-19-000072 · doc1.xml · nonDerivative · entry 2 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,000 Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:09 UTC | U.S. GOLD CORP. USAU · Entity 6127 | PurchaseCommon Shares | 1,300 | $0.87 | $1,135.81 |
DisclosureSEC source: 0001567619-19-000072 · doc1.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,300 Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 13:00 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-013331 · ownership.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,000 F1 · security: Represents a restricted stock grant issued pursuant to the Issuer's 2017 Equity Incentive Plan which vests 50% on the date of issuance and 50% on the one-year anniversary of the date of issuance. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 20:30 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantCommon Stock | 95,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-003654 · form4.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,000 F1 · price: Represents a restricted stock award issued pursuant to the U.S. Gold Corp. Equity Incentive Plan as compensation for the Reporting Person's service as Chief Operating Officer/Secretary of the Issuer. Read SEC document |
| December 22, 2017 Filed Dec 27, 2017 23:47 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantOption · Derivative | 250,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001493152-17-015143 · form4.xml · derivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 250,000 shares Expires 2022-12-22 F2 · price: Option Award is compensation for the Reporting Person's service as Chief Operating Officer/Secretary of the Issuer. F1 · derivative.exercise_date: Represents an option award under the U.S. Gold Corp. Equity Incentive Plan (the "Option Award"), of which one-quarter shall vest immediately and three-quarters shall vest in equal yearly installments over a three year period. F3 · balance_after: Includes options vested or to be vested within 60 days pursuant to the Option Award. Read SEC document |
| December 19, 2017 Filed Dec 22, 2017 01:19 UTC | Eloxx Pharmaceuticals, Inc. SVOND · Entity 7180 | GrantCommon Stock Option (Right to Buy) · Derivative | 27,500 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001144204-17-064890 · tv481927_4.xml · derivative · entry 1 RECTOR DAVID · CIK 0001167113 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2027-12-19 F1 · price: Such options were granted to Mr. Rector under Sevion Therapeutics Inc.'s ("Sevion's") 2008 Incentive Compensation Plan for services performed during Sevion's fiscal year ended June 30, 2017 and the portion of Sevion's fiscal year ended June 30, 2018 leading up to the closing of Sevion's transaction with Eloxx Pharmaceuticals, Ltd. (the "Transaction"), which occurred on December 19, 2017. In connection with the closing of the Transaction, Sevion effected a 1-for-20 reverse stock split and changed its corporate name to "Eloxx Pharmaceuticals, Inc." Such options were granted on a post-split basis and are immediately exercisable at an exercise price of $6.00 per share, which is equal to the closing selling price of Sevion's common stock on December 19, 2017, as reflected on a post-split basis. Read SEC document |
| November 13, 2017 Filed Nov 13, 2017 23:26 UTC | U.S. GOLD CORP. USAU · Entity 6127 | PurchaseCommon Stock | 10,000 | $1.36 | $13,600.00 |
DisclosureSEC source: 0001493152-17-012958 · form4.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,255 Read SEC document |
| August 23, 2017 Filed Sep 6, 2017 18:11 UTC | U.S. GOLD CORP. USAU · Entity 6127 | GrantCommon Stock | 70,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-17-010261 · form4.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · COO of Sub., Gold King Corp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,255 F1 · price: Issued pursuant to the Issuer's 2017 Equity Incentive Plan in consideration for the Reporting Person's role as an officer of the Issuer's subsidiary, Gold King Corp., in lieu of an annual cash bonus for period May 1, 2016 through April 30, 2017. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 19:11 UTC | POLARITYTE, INC. COOL · Entity 117561 | GrantCommon Stock, par value $0.001 per share | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-16-007537 · form4-12052016_041208.xml · nonDerivative · entry 1 RECTOR DAVID · CIK 0001167113 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · shares: Represents a restricted stock award (the "Restricted Stock Award") pursuant to the Issuer's 2017 Equity Incentive Plan (the "Plan"), which Plan is subject to stockholder approval. F1 · price: Represents a restricted stock award (the "Restricted Stock Award") pursuant to the Issuer's 2017 Equity Incentive Plan (the "Plan"), which Plan is subject to stockholder approval. F2 · balance_after: Represents (i) the Restricted Stock Award, (ii) a restricted stock award of 16,667 shares granted pursuant to the Issuer's 2014 Equity Incentive Plan and (iii) a restricted stock award of 8,333 shares granted pursuant to the Issuer's 2016 Equity Incentive Plan of which 50% vested on April 25, 2016 and 50% vested on December 1, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.